Metoclopramide Accord (Metoclopramide Hydrochloride Anhydrous)

The drug blocks dopamine D2 receptors in the brain's chemoreceptor trigger zone, which reduces the signal that triggers nausea and vomiting. In the gastrointestinal tract it also blocks D2 receptors, increasing acetylcholine release and enhancing motility, while modestly affecting serotonin receptors to further support its pro‑kinetic action.

The appropriate dose of Metoclopramide Accord is determined by the prescribing clinician based on the patient’s condition, age, renal function and other clinical factors. Healthcare professionals should follow local prescribing guidelines and adjust the regimen as needed for each individual.

Metoclopramide is classified as pregnancy category B1, indicating that animal studies have not shown risk and there are no adequate human studies. It may be used during pregnancy only if the potential benefit justifies the potential risk. Limited data are available for breastfeeding, and a risk‑benefit assessment should be performed by the prescriber.

To place an order, submit an enquiry on the Metoclopramide Accord product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other antiemetics such as ondansetron or antihistamines, Metoclopramide offers both anti‑nausea and pro‑kinetic effects, making it useful for conditions involving delayed gastric emptying. However, it carries a higher risk of extrapyramidal side effects, so clinicians often reserve it for patients who need both actions or who do not respond to alternatives.

Metoclopramide Accord tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in bathrooms or near heat sources.

The medication is taken orally, usually with a glass of water. It may be taken with or without food, depending on the prescriber’s instructions. Patients should follow the dosing schedule provided by their healthcare professional and should not crush or chew the tablets unless specifically advised.

Serious adverse reactions include extrapyramidal symptoms such as acute dystonia, tardive dyskinesia with long‑term use, and neuroleptic malignant syndrome. Patients should be instructed to seek immediate medical attention if they experience muscle rigidity, high fever, severe agitation, uncontrolled movements or any signs of an allergic reaction.

Metoclopramide should be avoided in individuals with known hypersensitivity to the drug, those with pheochromocytoma, seizure disorders, or severe depression. It is also contraindicated in patients taking antipsychotics that block dopamine receptors, as the combination can increase the risk of serious neurological side effects.